Clinical Trials Directory

Trials / Completed

CompletedNCT01480934

Evaluation of Posterior Capsule Opacification in Eyes With Diabetes Mellitus

A Prospective Evaluation of Posterior Capsule Opacification in Eyes With Diabetes Mellitus -A Case Control Study

Status
Completed
Phase
Study type
Observational
Enrollment
150 (actual)
Sponsor
Iladevi Cataract and IOL Research Center · Academic / Other
Sex
All
Age
50 Years – 75 Years
Healthy volunteers
Accepted

Summary

To compare the development of posterior capsule opacification (PCO) between eyes with and without a history of diabetes mellitus (DM) after single-piece hydrophobic acrylic intraocular lens (IOL) implantation 4 years postoperatively.Diabetes mellitus would not increase the incidence of PCO at 4 years.

Detailed description

There is a paucity of available literature that prospectively evaluates the development of PCO with the single-piece hydrophobic acrylic IOL implantation in diabetic versus non-diabetic eyes on a long-term basis. Therefore, this study was designed to compare the degree of PCO after cataract surgery between diabetic and age-matched non-diabetic patients. This prospective, observational case control study comprised patients who underwent phacoemulsification .The patients were asked to return for postoperative follow-up visits at 1 month, 1 year and 4 years. the digital images were analyzed for PCO .

Conditions

Timeline

Start date
2005-06-01
Primary completion
2010-01-01
Completion
2010-06-01
First posted
2011-11-29
Last updated
2011-11-29

Source: ClinicalTrials.gov record NCT01480934. Inclusion in this directory is not an endorsement.